Surface Oncology, Inc. (SURF) has 37 open-market insider trades by 24 insiders since 2018. The most active filer is Jeff Goater, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David S. Grayzel | Dir | — | 3 | $46.0M | 2023-09-08 |
| Atlas Venture Fund IX, L.P. | 10% Owner | — | 1 | $30.8M | 2020-12-17 |
| Novartis Institutes for BioMedical Research, Inc. | 10% Owner | — | 1 | $11.5M | 2018-04-23 |
| Jeff Goater | Dir | — | 4 | $5.5M | 2023-09-08 |
| EcoR1 Capital, LLC | 10% Owner | — | 1 | $4.8M | 2020-09-01 |
| Steven Edward Hall | 10% Owner | — | 1 | $4.0M | 2018-04-23 |
| Armen Shanafelt | Dir10% Owner | — | 1 | $4.0M | 2018-04-23 |
| Anthony A. Florence Jr. | 10% Owner | — | 2 | $3.5M | 2020-05-20 |
| Peter J. Barris | 10% | — | 1 | $2.0M | 2018-04-23 |
| Patrick J. Kerins | 10% Owner | — | 1 | $2.0M | 2018-04-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Alison Oneill | Chief Medical Officer | Sell | $7K | 2023-08-01 |
| Robert W. Ross | CEO | Sell | $16K | 2023-08-01 |
| Chandra Adams | Deputy GC | Sell | $4K | 2023-08-01 |
| Jessica Fees | CFO | Sell | $9K | 2023-08-01 |
| Henry C. Rath | Chief Business Officer | Sell | $10K | 2022-08-03 |
| Vito J. Palombella | Chief Scientific Officer | Sell | $8K |
Companies that share insiders with SURF, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-08-03 |
| Jessica Fees | CFO | Sell | $10K | 2022-08-03 |
| Robert W. Ross | CEO | Sell | $18K | 2022-08-03 |
| Jeff Goater | Director | Sell | $1.6M | 2021-07-21 |
| Alison Oneill | — | Sell | $181K | 2021-07-21 |
| Liisa I. Nogelo | CLO | Sell | $321K | 2021-07-21 |
| Jessica Fees | CFO | Sell | $242K | 2021-07-21 |
| Robert W. Ross | CEO | Sell | $204K | 2021-07-21 |
| Jeff Goater | Director | Sell | $3.8M | 2021-06-10 |
| Robert W. Ross | Chief Medical Officer | Sell | $11K | 2021-02-16 |